HCPCS Level IIdrugActive
J7203
Factor ix recomb gly rebinyn
BETOS: O1E
Effective: 2019-01-01
Referenced in 5 policies
Description
Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Rebinyn
Manufacturer
Novo Nordisk, Inc
HCPCS Dosage
1 IU
Billing Units
1.0000
4
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.